Laurus Labs jumps on outlook for 67% EBITDA growth
In short
Laurus Labs shares rose after analysts at Kotak Institutional Equities gave a Q2FY27 outlook. They expect EBITDA to grow 67% year on year to ₹680 crore, with margins at 31.2%.
This matters because it points to better profits ahead. The report does not say what will happen for sure, only that the forecast is stronger.
What the reporting says
Laurus Labs’ shares jumped after a publisher-supplied outlook cited by analysts at Kotak Institutional Equities projected 67% year-on-year EBITDA growth to ₹680 crore in Q2FY27, with margin expansion of 680 basis points to 31.2%. The reporting does not explain the stock move beyond that forecast. The immediate consequence is a stronger earnings expectation, while the actual result is still not known.
Why it matters
Laurus Labs was highlighted on a stronger Q2FY27 outlook, with Kotak Institutional Equities building in 67% year-on-year EBITDA growth to ₹680 crore and margin expansion to 31.2%. The source frames this as the basis for the stock’s move, but it does not provide the company’s own guidance or confirm actual results. The market implication is improved profitability expectations.